Chancity

Biotech Showcase 2027

Biotech Showcase brings together biopharma executives, investors and innovators in San Francisco.

Date
January 11, 2027
Location
San Francisco, CA
Audience
3,200+ global biopharma leaders, including 1,200+ investors

TL;DR

  • The 2027 event starts January 11 in San Francisco, California.
  • The organizer describes a gathering of more than 3,200 global biopharma leaders, among them over 1,200 investors.
  • The event lists more than 6,000 one-to-one meetings through partneringONE.

Source: informaconnect.com/biotech-showcase

Who you'll find in the room

Biopharma leaders

Biopharma leaders are among the stated audience.

Investors

Investors are included in the stated audience.

Innovators

Innovators are included in the stated audience.

Industry leaders

Industry leaders are included in the stated audience.

Featured speakers

117 listed

Julie Adrian

Co-Founder & CEO Alverium Health

Virginia Amann

Founder ENTENTE Network

Jim Anthony

Chief Commercial Officer & President Parexel Biotech

Annalee Armstrong

Senior Editor BioSpace

Somer Baburek

President, CEO & Board Member HERAbiotech

Thomas Barker

Partner, Co-Chair, Healthcare Department Foley Hoag

Vasundhara Bhargava

Deal Professional Principal Patient Square Capital

Gwendolyn Binder

President, Science and Technology Cabaletta Bio

Fritz Bittenbender

Board Chair, BIO & SVP Genentech

Eric Blouin

SVP, Oncology Ipsos Healthcare Advisory

Martin Brenner

CEO & CSO iBio

Steve Brozak

Managing Partner & President WBB Securities LLC

Grant Castor

SVP, Commercial Strategy & Operations Sentynl

Grace E. Colón

Board Chair, Aronora Biosciences, Bloom Science and Emm, Board Member BIO and MIT

Jonah Comstock

Editor in Chief pharmaphorum

Trish Costello

Founder & CEO Portfolia

Tamara Darsow

SVP, Global Business Development Novo Nordisk

Allison DeAngelis

Reporter STAT

Marc Dechamps

CEO Bioxodes

Lori Ellis

Market Intelligence Advisor Consultant

David Ewing Duncan

Journalist, Author Researcher

Jessica Federer

Board Member Angelini Ventures

Ryan Field

CEO Kernel

Eva Fortea-Verdejo

VP, Equity Research, Biotechnology Wells Fargo Corporate & Investment Banking

Alice Gilman

Co-Founder & COO R3 Biotechnologies

Jen Goldsack

CEO Digital Medicine Society (DiMe)

Jessica Green

Program Manager, Resilient Systems ARPA-H

Ignacio Guerrero-Ros

VP Russo Partners

Kimberly Ha

Founder & CEO KKH Advisors

Jay Hartenbach

President & COO Diakonos Oncology

Theresa Heah

CEO Eyexora

James Healy

Managing Partner Sofinnova Investments

Curt Herberts

Former President & COO Kriya Therapeutics

Echo Hindle-Yang

Founder & CEO MSQ Ventures

Lynelle Hoch

President, Cell Therapy Organization Bristol Myers Squibb

Tim Hunt

CEO Alliance for Regenerative Medicine

Nouhad Husseini

SVP, Head, BD & Corporate Strategy Regeneron Pharmaceuticals

Anthony Jarkowski, III

SVP, Primary Focus Lead, Head, Immuno-oncology Astellas

David Jenkins

SVP, Head, External Innovation and Research Ipsen

Alex Kadet

CBO Gero

Sanjay Kakkar

CEO Tensive

Konstantina Katcheves

SVP & Chief Business and Strategy Officer Acadia Pharmaceuticals

Natalie Kates

Acting Director, Scalable Solutions ARPA-H

Amanda Kay

Senior Partner & Chief Business Development Officer Flagship Pioneering

Hans Keirstead

Chairman Immunis, Inc.

Oliver Keown

CEO & Founder Oath Surgical

Themasap Khan

Co-Founder & Partner Luma Group

Navjeewan Khosla

Partner Novo Holdings Asia

Minji Kim

Entrepreneur in Residence Formation Bio

Mark Kotter

Executive Chairman, Scientific Founder clock.bio

Daniella Kranjac

Founding General Partner Avant Bio

Ken-ichiro Kuninobu

Co-founder & CEO FELIQS

Kyle LaHucik

Senior Reporter Endpoints News

Andrew Lam

Managing Director, Head, Biotech Private Equity Ally Bridge Group

Michael Langer

Co-Founder & Managing Partner T.Rx Capital

Kelly Laurel

CEO SurgiBox

Ron Leuty

Senior Reporter San Francisco Business Times

Jeremy Levin

Chairman & CEO Ovid Therapeutics Inc.

Raven Lin

CEO Pilatus Biosciences

Sean Lin

CEO ChemLex

Philippe Lopes-Fernandes

Executive VP & CBO Ipsen

Mr. Timothy Lu

Co-founder & CEO Senti Bio

Natalie Ma

Head, BD Deep Origin

Alastair MacDonald

Global Head, Medical Affairs & Growth Strategy Sciensus

Marinna Madrid

Co-Founder & Chief Product Officer Cellino

Katya Magonova

Managing Director, Commercial Advisory Syneos Health

George Magrath

CEO Opus Genetics

Maite Malet

Principal Asabys Partners

Michael Margolis

Senior Managing Director, Head, Healthcare Investment Banking Oppenheimer & Co. Inc.

Michael McCullar

CEO RegCell

Wyatt McDonnell

CEO Infinimmune

Jane Metcalfe

Executive Chair Human Immunome Project

Michael Meyers

Vice Chairman, Head, M&A and Strategic Advisory Services H.C. Wainwright & Co. LLC

Vivek Mittal

Partner, Managing Director & Head, Biopharma Health Advances

Aaron Morris

Co-Founder & CEO PostEra

Ravit Netzer

Co-Founder & CEO Scala Biodesign

Wonhee Oh

VP, Healthcare Investment Banking J.P. Morgan

Tim Opler

Managing Director, Global Healthcare Group Stifel

Jack O’Meara

CEO Aerska

Art Pappas

Managing Partner Pappas Capital

Mr. Neel Patel

Head, NewCo Business Development Flagship Pioneering

Ritish Patnaik

CEO Curve Biosciences

Adam Pearson

Chief Strategy Officer Astellas

Alex Philippidis

Senior Business Editor GEN

Maria Luisa Pineda

CEO & Co-Founder Envisagenics

Linda Pullan

Founder Pullan Consulting

Cameron Pye

Co-Founder & CEO Unnatural Products Inc.

Maha Radhakrishnan

Executive Partner Sofinnova Investments

Priyanka Rao

Venture Fellow H/L Ventures

Rachel Ravens

CEO & Partner 42Genetics, 46Health

Lori Reilly

COO PhRMA

Niels Riedemann

CEO InflaRx

MaryAnne Rizk

Managing Director, Head, Healthcare & Life Science Clinical Strategy Amazon Web Services (AWS)

Kate Rochlin

COO IN8bio

Beth Rogozinski

CEO Oncoustics

Peter Rubin

Executive Director No Patient Left Behind

Jarod Rutledge

Director, Biotech Investments Starbloom Capital

Helen Sabzevari

President & CEO Precigen

Amber Salzman

CEO Epicrispr Biotechnologies

Adam Schayowitz

Chief Development Officer Zymeworks

David Schull

President Russo Partners

Denise Scots-Knight

CEO Mereo BioPharma

Stacey Seltzer

Managing Partner & Founder Pontiva Healthcare Partners

Paul Sheehan

Program Manager, Resilient Systems ARPA-H

Joe Shonkwiler

Head, Healthcare & Life Science, Venture Capital BD Google

Kristina Simmons

Founder & Managing Partner Overwater Ventures

Curran Simpson

President and CEO REGENXBIO

Greg Skalicky

President EVERSANA

Bob Smith

Venture Partner, OrbiMed

Chairman Alliance for Regenerative Medicine

Tari Suprapto

Senior Director & Head, Global Innovation Sourcing Novo Nordisk

Ashish Tripathi

CEO Tzar Labs

Andy Udell

CCO Actinogen Medical

Brent Vaughan

CEO & Co-Founder Eratos Therapeutics, Inc.

Tracy Warren

Senior Managing Director Go Red for Women Fund, AHA Ventures, American Heart Association

Daniel Wee

Chief eXecution Officer Enveda

Emma Wheatley

Executive Director Access

Questions people ask

6 answered

The event starts January 11, 2027.

Biotech Showcase 2027 is held in San Francisco, California.

The organizer cites more than 3,200 global biopharma leaders, including over 1,200 investors.

The stated audience includes biopharma leaders, investors, innovators and industry leaders.

Dealmakers get the most from it: founders and executives courting capital, business development staff hunting for partners, and investors sourcing deals, since the organizer reports about 3,200 attendees, among them 1,200 or more investors, plus a scheduled meeting system run through partneringONE. The speakers include a Genentech SVP who chairs the BIO board, a deal professional from Patient Square Capital and reporters from STAT and BioSpace, which points to a finance and business audience, so bench scientists wanting deep technical sessions will get less from it.

Attendees at biopharma investor conferences in San Francisco usually wear business casual to smart business attire, often a blazer with no tie, since days are spent in back-to-back meetings. Layers suit San Francisco in January, along with comfortable shoes for moving between meetings.

Related events

Find more events with this kind of reach.

We score 300,000+ B2B events by decision-maker density, so you can find the next one for your ICP.

Also listed in